Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

May 29, 2023

Study Completion Date

May 29, 2023

Conditions
Type 2 DiabetesObesity
Interventions
DRUG

Formoterol Fumarate 12 micrograms Inhalation Powder

At time 60 minutes, a total of 48 micrograms will be inhaled within 3 minutes: 4 inhalations of 12 micrograms of fumarate formoterol (Oxeze® Turbuhaler®).

DRUG

Nicotinic Acid 50 MG Oral Tablet

a total dose of 1050 MG will be ingested. From time 0 to 180 minutes, doses of 150 MG will be repeated every 30 minutes.

OTHER

Acute Cold Exposure

Participants will be fitted with a liquid-conditioned tube suit. The liquid-conditioned tube suit will be perfused with 18°C water using a temperature- and flow-controlled circulation bath from time 0 to 180 min.

DIAGNOSTIC_TEST

Positron Emission Tomography (PET)

PET imaging using C11-palmitate (time 90), C11-acetate (time 120) and F18-Fluorodeoxyglucose (FDG) (time 150)

DIAGNOSTIC_TEST

Indirect calorimetry

will be repeated every hour, for 20 minutes, using Vmax29n.

DIAGNOSTIC_TEST

dual-energy x-ray absorptiometry (DEXA scan)

Whole body scan

PROCEDURE

Biopsy

After local anesthesia with 2% xylocaine without epinephrine, 100-200 mg of subcutaneous adipose tissue will be sampled by needle (14G) biopsy

PROCEDURE

iv lines

for stable tracer perfusion and blood sampling

PROCEDURE

Electromyogram (EMG)

Surface electrodes will be used to measure skeletal muscle activity and shivering intensity

Trial Locations (1)

J1H 5N4

Centre de recherche du CHUS, Sherbrooke

All Listed Sponsors
lead

Université de Sherbrooke

OTHER